• Johnson & Johnson Will Release Clinical Data to Researchers
    2 replies, posted
[url]http://www.counselheal.com/articles/8514/20140201/johnson-johnson-will-release-clinical-data-to-researchers.htm[/url] [QUOTE]Johnson & Johnson has announced that it will release its clinical trial data to researchers. This is a huge step forward because for years, drug-manufacturing companies have been persistent about not sharing any information they collect on their drugs. These companies have also avoided publishing any negative trials. Now, Johnson & Johnson has decided to work with the Yale School of Medicine's Open Data Access Project (YODA). "We really wanted a broad approach to contributing to advancing medical science through all of our products that touch patients in different ways," stated Joanne Waldstreicher, MD, Chief Medical Officer, Johnson & Johnson. YODA will be responsible for reviewing any requests from physicians seeking to acquire any available data on Johnson & Johnson's products. Since the partnership is new, physicians can only ask for data on products from the company's drug division. Johnson & Johnson stated that eventually, physicians could get access to data on its devices and consumer products. Once YODA accepts a request, the physician will be given the raw data, which include data on each participant. The participants' names, however, will be omitted. The researchers would be able to examine the data on their own terms. [/QUOTE]
"Review your requests, we will, but only data from drug division can you ask for." :v:
It's somewhat of a step forwards, but we've still got a mountain of other pharmaceutical companies like Roche that need to release all info too. We really need [b]every[/b] clinical trial to be fully written up and public domain, including trials that weren't finished. Ideally mandated by law.
Sorry, you need to Log In to post a reply to this thread.